HFM
AMED

Harvest Fund Management’s Amedisys AMED Stock Holding History

Harvest Fund Management’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-78
Closed -$20K – 770
2021
Q1 		$20K Sell
78
-20
-20% -$5.64K ﹤0.01% 626
2020
Q4 		$28K Buy
+98
New +$25.1K ﹤0.01% 453
2019
Q4 		– Sell
-469
Closed -$61K – 405
2019
Q3 		$61K Sell
469
-266
-36% -$34.6K 0.01% 245
2019
Q2 		$89K Buy
735
+324
+79% +$38.5K 0.01% 219
2019
Q1 		$51K Sell
411
-1,323
-76% -$166K 0.01% 269
2018
Q4 		$203K Sell
1,734
-4,087
-70% -$482K 0.04% 113
2018
Q3 		$727K Buy
+5,821
New +$643K 0.12% 45

Other funds holding AMED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Harvest Fund Management's AMED Position: Q2 2021 in Review

Harvest Fund Management sold out of Amedisys (AMED) in Q2 2021, closing a stake of 78 shares — an estimated $20K sold.

Harvest Fund Management first reported a position in AMED in Q3 2018 and held it in 7 quarters. The position peaked at $727K in Q3 2018. 375 funds tracked by Wall St. Rank hold AMED as of Q2 2021.

  • Harvest Fund Management reported no remaining Amedisys position as of Q2 2021 after selling out during the quarter.
  • Harvest Fund Management sold 78 Amedisys shares in Q2 2021, an estimated $20K.
  • Harvest Fund Management first reported a position in Amedisys in Q3 2018 and held it in 7 quarters.
  • Harvest Fund Management's Amedisys position peaked at $727K in Q3 2018.
  • 375 funds tracked by Wall St. Rank held Amedisys as of Q2 2021.

Based on Harvest Fund Management's 13F filing for Q2 2021, filed 11 Aug 2021.